Catapult Capital Management’s Novartis NVS Stock Holding History

Catapult Capital Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-11,160	Closed	-$927K	–	244
2014 Q4	$927K	Buy	+11,160	New	+$925K	0.24%	113
2014 Q1	–	Sell	-41,850	Closed	-$3.01M	–	244
2013 Q4	$3.01M	Buy	+41,850	New	+$2.91M	0.72%	48

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

BTS

BB&T Securities Richmond, Virginia $10.9B AUM 5.31% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MAA

Managed Account Advisors Jersey City, New Jersey $121B AUM 7.32% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Catapult Capital Management's NVS Position: Q1 2015 in Review

Catapult Capital Management sold out of Novartis (NVS) in Q1 2015, closing a stake of 11,160 shares — an estimated $927K sold.

Catapult Capital Management first reported a position in NVS in Q4 2013 and held it in 2 quarters. The position peaked at $3.01M in Q4 2013. 939 funds tracked by Wall St. Rank hold NVS as of Q1 2015.

Catapult Capital Management reported no remaining Novartis position as of Q1 2015 after selling out during the quarter.
Catapult Capital Management sold 11,160 Novartis shares in Q1 2015, an estimated $927K.
Catapult Capital Management first reported a position in Novartis in Q4 2013 and held it in 2 quarters.
Catapult Capital Management's Novartis position peaked at $3.01M in Q4 2013.
939 funds tracked by Wall St. Rank held Novartis as of Q1 2015.

Based on Catapult Capital Management's 13F filing for Q1 2015, filed 15 May 2015.